IDS Antikörper
Kurzübersicht für IDS Antikörper (ABIN7115175)
Target
Alle IDS Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Aufreinigung
- Protein A+G purification
-
Reinheit
- ≥95 % as determined by SDS-PAGE
-
Immunogen
- iduronate 2-sulfatase
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- WB: 1:500-1:1000, IHC: 1:20-1:200, IF: 1:20-1:200
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C for 12 months (Avoid repeated freeze / thaw cycles.)
-
Haltbarkeit
- 12 months
-
-
- IDS (Iduronate 2-Sulfatase (IDS))
-
Andere Bezeichnung
- Iduronate 2 sulfatase
-
Hintergrund
- Synonyms:IDS, iduronate 2 sulfatase, Idursulfase Background:Iduronate 2-sulfatase (IDS) is required for the lysosomal degradation of heparan sulfate and dermatan sulfate. Mutations causing IDS deficiency in humans result in the lysosomal storage of these glycosaminoglycans and Hunter syndrome, an X chromosome-linked disease. IDS is synthesized as two precursor forms of 76 and 90 kDa that are converted, through a 62 kDa intermediate, to 55 and 45 kDa mature polypeptides due to an internal proteolytic cleavage (PMID: 10838181).
-
Molekulargewicht
- 76 kDa, 55 kDa
-
Gen-ID
- 3423
-
UniProt
- P22304
-
Pathways
- Glycosaminoglycan Metabolic Process
Target
-